Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cresco Labs (CRLBF) Net Income towards Common Stockholders (2020 - 2026)

Cresco Labs filings provide 7 years of Net Income towards Common Stockholders readings, the most recent being -$13.1 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 9.42% to -$13.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$131.8 million, a 78.99% decrease, with the full-year FY2025 number at -$140.0 million, down 131.52% from a year prior.
  • Net Income towards Common Stockholders hit -$13.1 million in Q1 2026 for Cresco Labs, up from -$85.3 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $27.4 million in Q1 2022 to a low of -$161.3 million in Q4 2022.
  • Median Net Income towards Common Stockholders over the past 5 years was -$14.4 million (2025), compared with a mean of -$32.0 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: soared 115.22% in 2024 and later plummeted 1604.87% in 2025.
  • Cresco Labs' Net Income towards Common Stockholders stood at -$161.3 million in 2022, then surged by 101.63% to $2.6 million in 2023, then surged by 115.22% to $5.7 million in 2024, then plummeted by 1604.87% to -$85.3 million in 2025, then surged by 84.68% to -$13.1 million in 2026.
  • The last three reported values for Net Income towards Common Stockholders were -$13.1 million (Q1 2026), -$85.3 million (Q4 2025), and -$17.1 million (Q3 2025) per Business Quant data.